Low-dose radiotherapy: Mayday, mayday. We've been hit!
Strahlenther Onkol
.
2019 Apr;195(4):285-288.
doi: 10.1007/s00066-018-1412-1.
Epub 2018 Dec 18.
Authors
Oliver J Ott
1
,
Oliver Micke
2
,
Ralph Mücke
3
,
Marcus Niewald
4
,
Franz Rödel
5
,
Ulrich Schäfer
6
,
M H Seegenschmiedt
7
,
Meritxell Arenas
8
,
Benjamin Frey
9
,
Udo S Gaipl
9
;
German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD)
Affiliations
1
Department of Radiation Oncology, Universitätsklinikum Erlangen, Universitätsstr. 27, 91054, Erlangen, Germany. oliver.ott@uk-erlangen.de.
2
Department of Radiotherapy and Radiation Oncology, Franziskus Hospital, Bielefeld, Germany.
3
Department of Radiotherapy RheinMainNahe, Bad Kreuznach, Germany.
4
Department of Radiotherapy and Radiation Oncology, Universitätsklinikum des Saarlandes, Homburg, Germany.
5
Department of Radiotherapy and Oncology, Universitätsklinikum Frankfurt am Main, Frankfurt am Main, Germany.
6
Department of Radiotherapy, Klinikum Lippe GmbH, Lemgo, Germany.
7
Department of Radiation Oncology, Strahlenzentrum Hamburg, Hamburg, Germany.
8
Department of Radiation Oncology, Hospital Universitari Sant Joan de Reus, University of Rovira i Virgili, Tarragona, Spain.
9
Department of Radiation Oncology, Universitätsklinikum Erlangen, Universitätsstr. 27, 91054, Erlangen, Germany.
PMID:
30564845
DOI:
10.1007/s00066-018-1412-1
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Inflammation
Osteoarthritis*